Home

Prescribing & Medicines Management
page PM4
March 2005


Features


Technicians — include or exclude?

In this article, Steve Morris, chairman of the Faculty of Prescribing and Medicines Management board, asks who will support pharmacy technicians

The Faculty of Prescribing and Medicines Management (FPMM) was the first faculty set up under the College of Pharmacy Practice (CPP) to support the development of specialist areas of pharmacy practice. Created in 2001, it provides a strong and influential professional support body for UK pharmacists working, or with an interest, in prescribing and medicines management.

Current membership of the FPMM mainly consists of pharmacists working in primary care, either in GP practices or primary care organisations, but the faculty’s appeal to community and hospital pharmacists has the potential to increase as demonstration of competence becomes imperative to career development and remuneration.

As roles within pharmacy start to change, the skill mix debate is picking up momentum. Causative factors include the new community pharmacy contract, Agenda for Change and problems with recruitment and retention. Along with the development of new roles for pharmacists, the contribution of support staff will also change, with the possibility of relaxation of supervision at the forefront of the debate.

Extending faculty membership

The FPMM is starting to address the implications of altering the demographics of the pharmacy workforce. The articles of association of the CPP currently only allow UK registered pharmacists to join it. The question is, therefore, should the CPP open membership to pharmacy technicians or keep it within the preserve of pharmacists practising at the cutting edge of medicines management. The CPP has decided to consult on extending its membership base and this consultation with its members will take place in the next few months.

There are arguments both for and against allowing technicians to join the CPP. Many would argue that the pharmacist in charge of a pharmacy should be able to delegate control of the pharmacy to a responsible person (such as a pharmacy technician). And this person should be registered with a professional body. Registration of the delegated person will allow standards for conduct and responsibility to be developed. The Royal Pharmaceutical Society has already started to register technicians. Like pharmacists, the delegated person should be trained, accredited and reappraised annually via nationally-agreed competency frameworks.

Clinical governance arrangements should underpin community pharmacy developments and pharmacies must actively engage with primary care organisations to develop new approaches and to become accredited. Loss of registration must be the ultimate sanction for the responsible pharmacist or delegated person, or both, if clinical governance standards are not adhered to, with the pharmacist in charge of a pharmacy taking overall responsibility for events in the pharmacy.

If pharmacists are allowed to devolve a degree of responsibility to properly trained and registered technicians for the dispensing process or if technicians are to play a substantial role in medicines management, it would seem logical that they be supported by organisations, such as the FPMM — increased responsibility cannot be expected without substantial support arrangements being put into place. The FPMM supports pharmacists through workshops, accreditation of events and materials and conferences, and it might not be much harder to provide for non-pharmacists within these support arrangements. This might also foster closer working relationships and enhanced recognition of roles between the different people working within the medicines management arena.

Conversely, would opening doors to a wider membership diminish the appeal of the FPMM to its core members? As a fledgling organisation, the infrastructure of the faculty and its capacity to provide core services for its current members need to be considered. Although the role of technicians is, without question, recognised and valued, it is a different one from that of pharmacists. As such, different views and different support requirements would need to be accommodated. Technicians might require representation at board level and this could lead to a dilution of existing resources. Some think that the FPMM should consolidate its support for pharmacists before trying to stretch itself (too thinly) across other professions.

Competencies

Underpinning faculty membership is a set of competencies centred on medicines management. To achieve full FPMM and CPP membership, associates must demonstrate attainment of these competencies. Continuing professional development and reflective thinking around competencies is something that all pharmacists are having to come to terms with and the FPMM is currently reviewing its competency framework to ensure it is both relevant and congruous with other nationally recognised requirements.

Should non-pharmacists working within medicines management be assessed against the same competencies as pharmacists or should a different set of skills be demonstrated? If the same, then it could be argued that there is no difference between pharmacists and non-pharmacists. Conversely, some would say that the public have a right to expect standardisation of skills if limited responsibility is to be devolved. In any event, if non-pharmacists are to be supported by the FPMM then should demonstration of an alternative set of competencies result in full FPMM (and hence CPP) membership or should that remain the right of pharmacists only?

Moving forward

In summary, the CPP’s options are simple:

· Retain the status quo and allow only pharmacists to become associate and full FPMM members
· Allow non-pharmacists to become associate FPMM members only
· Allow non-pharmacists to become both associate and full FPMM members

We will either end up with a specialised pharmacist workforce within medicines management, supported in depth by its own faculty, or a multifaceted team with, perhaps, a stronger focus on breadth rather than depth of support. Consultation will be the key.

Back to Top


©The Pharmaceutical Journal